Generics 22

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Busulfan manufacturers

22 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

22 products found

busulfan

Injection 6 mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Costa Rica , Malta , Panama , Peru
Manufacturer #1338
The company is a prominent player in the generic pharmaceutical industry with strong capabilities in research, development, manufacturing, and commercialization. It has received multiple GMP certifications from international regulatory bodies, such as those from Bavaria, Switzerland, Slovenia, and Mexico, underscoring its commitment to quality and global standards. Recognized for its innovation, the company has earned numerous product patents and prestigious awards, such as the Pharmexcil Patent Award. With ISO certifications for quality and environmental management, a robust infrastructure of five manufacturing facilities in India, and strategic partnerships for producing HIV/AIDS drugs, the company demonstrates a strong focus on expanding its global footprint and delivering affordable healthcare solutions.

Manufacturer usually replies in 7 days

busulfan

Vials, injection 60 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only
Manufacturer #17708
This pharmaceutical company boasts over 75 years of experience in manufacturing, research & development, and global supply chain management for specialty pharmaceuticals. They have introduced over 100 unique molecules to the Indian market and hold prominent positions in 9 therapeutic segments across regions including the EU and North America. Their product portfolio is extensive, encompassing injectables, antibiotics, antifungals, antipyretics, cardiovascular medications, central nervous system drugs, corticosteroids, gastrointestinal treatments, and nutraceuticals. They also offer pediatric formulations and vaccines. The company emphasizes quality, affordability, and innovation, reflected in their GMP certifications and numerous product patents. Their key therapeutic areas include infectious diseases, pain management, cardiology, and pediatrics, with principal dosage forms ranging from oral solutions to injections.

Manufacturer usually replies in 4 days

busulfan

Injection 6 mg/ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #15176

Manufacturer usually replies in 5 days

Want to see all 22 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Busulfan:

Busulfan, also known under the popular company brand names of Myleran (GlaxoSmithKline) and Busulfex IV (Otsuka America Pharmaceutical Inc), is a medication used in cancer chemotherapy treatments. Busulfan was originally approved by the FDA in the United States for the treatment of chronic myeloid leukaemia in 1999. In which it remained the mainstay chemotherapeutic treatment until it was predominantly displaced by the drug imatinib. Busulfan, however, still is used to a degree as a result of the drug's relatively low cost. This has made it attractive to busulfan manufacturers and busulfan suppliers, as it has entered the generic drugs space. Currently, it can frequently be found on pharmaceutical for sale list of distributors across the global marketplace, where it is available to order wholesale at a variety of cost and price points.

Method of action of busulfan:

Busulfan belongs to a group of drugs termed alkylating agents. These contain 2 labile methanesulfonate groups attached to opposite ends of a 4-carbon alkyl chain. Post hydrolysation, the methanesulfonate groups are released and carbonium ions are produced. This causes the acylation of DNA, which intern results in interference of DNA replication and RNA transcription. Culminating in disruption of nucleic acid function. This mechanism of action is enabled through alkylation which produces guanine-adenine intrastrand crosslinks. These crosslinks occur through an SN2 reaction, with guanine N7 mediating a nucleophilic attack on the carbon adjacent to the mesylate leaving group. This causes damage to the cellular DNA that can not be repaired by cellular machinery, thus triggering the cell to undergo apoptosis.

Form and dosage of busulfan:

The final form and packaging of busulfan are dependent on the manufacturers and suppliers, as well as the specific distributors and order. However, busulfan can typically be found for wholesale in forms including a solution for infusion, tablets, solution for injection, ampules, and vials. The typical dose administered is highly dependent on the patient and the specific underlying indication. As such it will vary on a patient by patient basis. For further information please refer to the manufacturers’ literature or contact a relevant healthcare provider.

Busulfan on Pipelinepharma:

Currently, at the time of writing, we have found 7 verified busulfan manufacturers and busulfan suppliers from our online global list of B2B sellers. These manufacturers, suppliers, and distributors are located in various countries including Canada, India, and Turkey. Each company and their pharmaceutical products list displayed on our online B2B platform has been verified by the Pipelinepharma team. This ensures seller reputability and reduces sourcing mileage, allowing for a fluent business experience for all involved parties.

Price of Busulfan and how to buy:

A cursory search online reveals an approximate wholesale cost for busulfan to be £69.02 for 2 mg x 25 tablets, £1610.00 for 8 x 6 mg per 1 ml ampules, and £2157.52 for 8 x 6 mg per 1 ml. These values are indicated for the NHS in the UK. As such they are only intended to serve as a generalization of the current market conditions.

Although the prices on the B2B wholesale Pipelinepharma marketplace remain confidential between both B2B parties, the seller may choose to list the desired price to facilitate the online transaction. If so, an ‘Accept’ and ‘Negotiate’ button will be displayed through the online interface, with a ‘Get offer’ button being shown in the absence.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible